Nucleoside analog GS‐441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid‐19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nucleoside analog GS‐441524: pharmacokinetics in different species, safety, and potential effectiveness against Covid‐19

Published:2022-04 Issue:2 Volume:10 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacology Res & Perspec

Author:

Rasmussen Henrik Berg¹²^ORCID,Thomsen Ragnar³,Hansen Peter Riis⁴

Affiliation:

1. Institute of Biological Psychiatry Mental Health Centre Sct. Hans Roskilde Denmark

2. Department of Science and Environment Roskilde University Center Roskilde Denmark

3. Section of Forensic Chemistry Department of Forensic Medicine Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark

4. Department of Cardiology Herlev and Gentofte Hospital Hellerup Denmark

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.945

Reference64 articles.

1. Drug repurposing in COVID-19: A review with past, present and future

2. Remdesivir for the Treatment of Covid-19 — Final Report

3. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

4. Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials

5. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperforin, the major metabolite of St. John’s wort, exhibits pan-coronavirus antiviral activity;Frontiers in Microbiology;2024-08-08

2. Discovery of C-Linked Nucleoside Analogues with Antiviral Activity against SARS-CoV-2;ACS Infectious Diseases;2024-04-23

3. Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections;Viruses;2024-04-22

4. Nanopore Signatures of Nucleoside Drugs;Nano Letters;2023-10-11

5. Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China;European Journal of Medicinal Chemistry;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3